Calliditas to participate in upcoming investor conferences
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced its management’s participation in the following investor conferences:· The Guggenheim Genomic Medicines and Rare Disease Days Conference, which is being held in person April 3 at the Lotte New York Palace. Calliditas CEO Renee Aguiar-Lucander will participate in a company fireside chat and there will also be a KOL Panel regarding the evolution of IgA nephropathy treatment. · The Kempen Life Sciences Conference, which will be held in person in Amsterdam on April 25 – 26. Details for both